I liked the transparency of the letter. I also note that a lot of it focused on Lifx and rightly so. I see this as the future and main product of the company with OHM etc... playing second fiddle. Hence the cost reductions focused there.
Overall I am positive on both the letter and the 4c.... as I said lots of candour and transparency I thought.
Key part is expectation of profitability this year.